2nd International Urologic Cancer Symposium

SEPTEMBER 7-9, 2017

Stern Auditorium
1468 Madison Avenue
New York, NY

Come early and join us on Wednesday, September 6th for a special day of celebration in recognition of our Diamond Jubilee – 75th Anniversary – Mount Sinai in the Atrium at 1468 Madison Avenue – Free for all conference registrants!

Course Director

Ash Tewari, MBBS, MCh

Course Co-Directors

Ketan K. Badani, MD
Nina Bhardwaj, MD, PhD
Carlos Cordon-Cardo, MD, PhD
William Oh, MD

Site Directors

Mantu Gupta, MD
Michael A. Palese, MD

Faculty Spotlight

Meet the Course Director
Dr. Ash Tewari, MBBS, MCh

Dr. Ash Tewari is an innovator in the fields of robotic prostate cancer surgery and prostate cancer treatment. He also designated various grades of nerve-sparing utilizing information from MRIs, allowing for incremental nerve-sparing particularly in cases that would have not previously qualified without this graded approach. He has described traction free and athermal nerve-sparing techniques and developed an innovative Detrusor wrap technique for early urinary continence.

Working with genitourinary pathologists and scientists from the University of Hamburg, he is currently evaluating the role of MRI-guided NeuroSAFE ® and sphinctersafe approaches in expanding opportunities for nerve-sparing. An active researcher and surgeon scientist, he is one of only a few robotic surgeons to be awarded a NIH R01 grant, for the investigation of real-time tissue identification during prostate cancer surgery.

Course Co-Director

Ketan Badani, MD

Icahn School of Medicine at Mount Sinai

Ketan Badani is the Vice Chairman of Urology and Director of the Robotic Surgery Program and Kidney Cancer Program at the Mount Sinai Health System in New York City. He has been the director of several large multi-organ robotic surgery programs over the past 10 years, and has an experience of over 5,000 robotic surgeries to date.

Dr. Badani has been involved since the early days of robotic surgery and in 2004 led one of the initial teams that developed robotic kidney surgery. He has published extensively on the topic with over 150 peer reviewed manuscripts and demonstrated his surgical techniques in over 20 countries. A true “surgeon-scientist”, Dr. Badani has a robust clinical and basic science research laboratory to study genomic profiles and patient derived Xenograft models of renal cell carcinoma subtypes.

Patrick Walsh, MD,

The Johns Hopkins School of Medicine

Professor Walsh is recognized worldwide as the inventor of nerve sparing radical prostatectomy for the treatment of prostate cancer. His surgical technique has substantially improved the potency and continence of prostate cancer patients, enhanced their quality of life and significantly reduced the risks of post-operative mortality and progression to metastasis. His surgery became one of the most widely used strategies for treating organ confined prostate cancer.

Robert Uzzo, MD, FACS

Fox Chase Cancer Center – Temple Health

Nationally known as a leader in the field of urologic oncology, Dr. Uzzo has made important clinical, scientific and educational contributions to the Department of Surgery.

A fellow of the American College of Surgeons, Uzzo has consistently ranked among Castle Connolly’s and Philadelphia magazine’s “Top Docs” in urology. He is a national principal investigator for a clinical trial by the Eastern Cooperative Oncology Group to evaluate new, targeted therapies for kidney cancers and immunotherapy. He is the author of more than 350 chapters, articles, books and abstracts on urologic tumors and has presented hundreds of regional, national and international lectures.

In addition to his extensive clinical practice, he oversees research laboratory initiatives studying molecular mechanisms of genitourinary cancers. In 2003, he was promoted from Associate Professor to Professor with tenure in Fox Chase’s division of medical science.

Inderbir S. Gill, MD, MCh

Chairman and Donald G. Skinner Distinguished Professor – Department of Urology at the University of Southern California (USC), Los Angeles

Executive Director – USC Institute of Urology and Associate Dean (Clinical Innovation) for the Keck School of Medicine at USC

He completed medical school, surgery residency, and urology residency in India before moving to the USA in 1989, where he completed a 2-year fellowship in renal transplantation and renovascular surgery at the Cleveland Clinic, and a second urology residency at the University of Kentucky Medical Center in 1995.

He joined University of Southern California in March 2009, prior to which he was at the Cleveland Clinic for almost 12 years from 1997-2009.

Inaugural Symposiums:
Immunotherapy of Urologic & GU Cancers and
World Consortium on Advanced Urologic Cancer

Mount Sinai faculty, residents, employees and voluntary faculty are eligible for scholarship, and must have a coupon code, please contact Carrie Brennan, Department of Urology for information @ caroline.brennan@mountsinai.org